Asymptomatic Short QT Syndrome with Family History of Sudden Cardiac Death

This protocol applies to patients with Short QT syndrome who are currently asymptomatic yet carry a family history of sudden cardiac death. The presence of this family history places this group at elevated concern and shapes the clinical approach even in the absence of personal symptoms.

Management in this setting involves an antiarrhythmic pharmacological strategy, with ongoing monitoring required for QT-interval effects throughout the course of therapy.

The full structured regimen — including agent selection, monitoring criteria, and the complete decision pathway — is available via the protocol below.